An IBJ analysis of political giving this election by CEOs of Indiana’s biggest companies found 56 executives donated $650,000 to nearly 92 organizations and candidates seeking federal office.
Lilly’s revenue in the United States rose 11 percent year-over-year, to $3.4 billion, thanks largely to rising sales of diabetes drugs Trulicity and Basgalar, cancer treatment Verzenio and psoriasis medication Taltz.
Nearly 650 Indianapolis-area janitors represented by the Service Employees International Union work for just eight firms that clean downtown office buildings.
The escalation in per-share price—which far exceeds that of other recent deals involving Indiana public companies—reflects the unique nature of M&A in the pharmaceutical realm.
Indianapolis-based Lilly is working with advisers to gauge interest in selling off a selection of older drugs for antibiotics and central nervous system diseases in China.
The project will give the Indianapolis-based pharmaceutical company upgraded lab space as it pushes to launch more drugs for diabetes, cancer, pain and other ailments.
New employees at Eli Lilly and Co. get a letter encouraging them to join one of the pharmaceutical firm’s affinity groups. There’s one for African Americans, one for Latino employees—and four for Asians.
It’s the foundation’s first capital campaign since 2010, when it raised $200 million. The money will be used for pediatric research, patient care, maternity and newborn health, and family support programs.
Makers of antidepressants and antipsychotics like Indianapolis-based Eli Lilly and Co., AstraZeneca, Pfizer, Allergan, Bausch Health and Otsuka Holdings might face new challenges and may be deterred from price hikes.
At issue in the five-year legal dispute was whether Dr. Rick Sasso was properly compensated for various inventions, and whether Minnesota-based Medtronic paid him sufficient royalties as spelled out in their agreements.
Agricultural and ag-technology firms in Indiana and throughout the Midwest are about to get a major shot of fertilizer from a California accelerator with blue-chip partners that plans to expand here.
Developers of 16 Tech—a consortium of offices, laboratories, housing and retail space—believe the campus will become a powerful economic engine by fostering collaboration and innovation.
The driving force behind the explosive growth of Salesforce’s Indianapolis-based Marketing Cloud unit stays out of the local spotlight but is internationally renowned in tech circles.
David Johnson, who has led the life science advocacy and investment group for 14 years, will take over full-time leadership of the Central Indiana Corporate Partnership in 2019.
The Indianapolis drugmaker said its 2-year-old anti-inflammatory medicine showed superiority in a head-to-head trial against Humira, the world’s best-selling drug, for treating psoriatic arthritis.
The Greenfield-based company, which staged its initial public offering in September, said the restructuring is intended “to streamline its international operations."
Several well-known Indiana companies were acquisition targets, including biotech firm Endocyte Inc., retailer The Finish Line Inc., racino owner Centaur Gaming, auto body chain Church Brothers Collision Repair, banking company MainSource Financial Group, and gas and electric utility Vectren Corp.
